No abstract

The old world date mite, Oligonychus afrasiaticus (McGregor) (Acari: Tetranychidae) is a severe spider mite pest of date palm in most of the Middle East and North Africa. Considering that nothing is known about the performance of phytoseiid predators against O. afrasiaticus , biology, predation, and life table parameters of Cydnoseius negevi (Swirski and Amitai) and Neoseiulus barkeri Hughes (Acari: Phytoseiidae), collected from date palm orchards, were studied under laboratory conditions (25, 35°C and 35 ± 10% RH) as a first step to understand their effectiveness against all mobile life stages of O. afrasiaticus . For both predators, oviposition period was significantly shorter at 35°C than at 25°C. The following parameters were obtained for C. negevi and N. barkeri at 25 and 35°C, respectively: female longevity, 31.8, 20.1, 35.7, 27.4 d; fecundity, 21.6, 38.0, 18.8, 34.8 eggs per female; oviposition period, 23.9, 13.7, 25.9, 18.1 d. Total predation of C. negevi and N. barkeri female was 246.0, 270.0, 227.6, 205.3 prey at 25 and 35°C, respectively. Rectal plugs were observed attached to the opisthosoma of some adult females of N. barkeri , which often cause the mite to stick to the surface. Life table parameters were estimated as net reproductive rate ( R0 ) 10.44, 17.35, 10.19, 13.84, intrinsic rate of increase ( rm ) 0.14, 0.19, 0.13, 0.16 d −1 , finite rate of increase (λ) 1.15, 1.21, 1.12, 1.17 d −1 , generation time ( T ) 17.03, 15.17, 17.83, 16.61 d, doubling time (DT) 04.95, 03.64, 05.33, 04.33 d for C. negevi and N. barkeri at 25 and 35°C, respectively. The values of intrinsic rate of increase and net reproductive rate were higher in C. negevi than N. barkeri at both temperature regimes. Therefore, it could be concluded that C. negevi performance was better than N. barkeri against O. afrasiaticus and can be considered as a valuable addition to the existing methods for spider mites control.

Background The overuse of short-acting β2-agonists (SABA) is associated with poor asthma control. However, data on SABA use in the Gulf region are limited. Herein, we describe SABA prescription practices and clinical outcomes in patients with asthma from the Gulf cohort of the SABA use IN Asthma (SABINA) III study. Methods In this cross-sectional study conducted at 16 sites across Kuwait, Oman, and the United Arab Emirates, eligible patients (aged ≥ 12 years) with asthma were classified based on investigator-defined disease severity guided by the 2017 Global Initiative for Asthma report and by practice type, i.e., respiratory specialist or primary care physician. Data on demographics, disease characteristics, and prescribed asthma treatments, including SABA, in the 12 months prior to a single, prospective, study visit were transcribed onto electronic case report forms (eCRFs). All analyses were descriptive in nature. Continuous variables were summarized by the number of non-missing values, given as mean (standard deviation [SD]) and median (range). Categorical variables were summarized by frequency counts and percentages. Results This study analyzed data from 301 patients with asthma, 54.5% of whom were treated by respiratory specialists. Most patients were female (61.8%), with a mean age of 43.9 years, and 84.4% were classified with moderate-to-severe disease, with a mean (SD) asthma duration of 14.8 (10.8) years. Asthma was partly controlled or uncontrolled in 51.2% of patients, with 41.9% experiencing ≥ 1 severe exacerbation in the 12 months preceding their study visit. Overall, 58.5% of patients were prescribed ≥ 3 SABA canisters, 19.3% were prescribed ≥ 10 canisters, and 13.3% purchased SABA over-the-counter (OTC) in the 12 months before the study visit. Most patients who purchased OTC SABA (92.5%) also received SABA prescriptions. Inhaled corticosteroid/long-acting β2-agonist combinations and oral corticosteroid bursts were prescribed to 87.7% and 22.6% of patients, respectively. Conclusions SABA over-prescription was highly prevalent in the Gulf region, compounded by purchases of nonprescription SABA and suboptimal asthma-related outcomes. Increased awareness among policymakers and healthcare practitioners is needed to ensure implementation of current, evidence-based, treatment recommendations to optimize asthma management in this region. Trial registration NCT03857178 (ClinicalTrials.gov).

Eight species of phytoseiid mites are reported from date palm orchards in Saudi Arabia. Seven of them were first records forthis country: Neoseiulus bicaudus (Wainstein), N. conterminus (Kolodochka), N. makuwa (Ehara), N. rambami (Swirski &Amitai), Proprioseiopsis asetus (Chant), P. messor (Wainstein), P. ovatus (Garman). Neoseiulus makuwa and P. asetus arerecorded from the Middle East and North Africa for the first time. One new species is described from Bermuda grass, Neoseiu-lus saudiensis n. sp. The new species is most similar to Neoseiulus alpinus (Schweizer) and N. marginatus (Wainstein). A key for identification of the included species is provided.

No abstract